Analysis of body composition change of diabetic patients by aggressive exercise therapy for 3 months
- Conditions
- Type 2 diabetes, obesity, metabolic syndrome
- Registration Number
- JPRN-UMIN000032163
- Lead Sponsor
- The University of Tokyo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 13
Not provided
Patients applicable to even one of the following are not included. 1) Those considered to be inappropriate for exercise therapy due to the progress of complications of diabetes (retinopathy: pre-proliferative retinopathy / proliferative retinopathy patients, nephropathy: CKD stage G3b or more, Patients with neuropathy: autonomic nervous disorder, orthostatic hypotension, disappearance of respiratory arrhythmia, and resting tachycardia clearly recognized) 2) Patients with a history of macroangiopathy 3) Patients who violate absolute contraindications or relative contraindications of treadmill examinations(According to guidelines on rehabilitation in cardiovascular disease (2012 revised edition)). Patients who were positive for treadmill examination 4) Users using implantable medical electrical equipment such as pacemakers 5) Female patient during pregnancy, lactating 6) Patients scheduled for surgery within 6 months 7) Patients suffering from malignant tumors 8) Patients whose body composition is extremely biased, patients who may interfere with accurate measurement of body composition 9) Patients who do not satisfy the measurement objectives recommended for body composition measuring instruments 10) Patients with obvious dementia 11) Patients with mental illness 12) Patients who have orthopedic disease and difficult exercise therapy 13) Patients whose visit to our hospital outpatient is irregular 14) Patients participating in other clinical research and clinical trials 15) Patients judged inappropriate as subjects by this research director
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change rate of visceral fat area
- Secondary Outcome Measures
Name Time Method Skeletal muscle mass, skeletal muscle ratio, HbA1c, body weight, body fat percentage, subcutaneous fat area, change rate of subcutaneous fat area, grip strength, walking speed, fasting blood sugar, fasting insulin, change in self management (questionnaire), Locomo 25 (questionnaire), dietary habit (questionnaire)